Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/22/2009US20090264412 Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor And A Glucocorticoid Receptor Agonist To Minimize The Side Effects Associated With Glucocorticoid Receptor Agonist Therapy
10/22/2009US20090264411 Fused thiophene derivatives as mek inhibitors
10/22/2009US20090264410 Therapeutic compounds and uses thereof
10/22/2009US20090264409 Bicyclic Heterocyclic p-38 Kinase Inhibitors
10/22/2009US20090264408 Extended release dosage forms of quetiapine
10/22/2009US20090264407 Substituted Sulfonamide Compounds
10/22/2009US20090264406 3-methyl-imidazo[1,2-b]pyridazine derivatives
10/22/2009US20090264405 Cetp Inhibitors
10/22/2009US20090264404 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
10/22/2009US20090264403 Novel azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
10/22/2009US20090264402 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid and having improved pharmacological properties
10/22/2009US20090264401 Substituted pyrimidin-5-carboxamides 281
10/22/2009US20090264400 Substituted Sulfonamide Compounds
10/22/2009US20090264399 Heterocyclic janus kinase 3 inhibitors
10/22/2009US20090264398 Method for inducing tumor apoptosis by increasing nitric oxide levels
10/22/2009US20090264397 Highly fluorinated oils and surfactants and methods of making and using same
10/22/2009US20090264396 17Alpha, 21-Dihydroxypregnene esters as antiandrogenic agents
10/22/2009US20090264395 Progesterone for the treatment or prevention of spontaneous preterm birth
10/22/2009US20090264394 Nitrooxy derivatives of glucocorticoids
10/22/2009US20090264393 Nitrooxy derivatives of glucocorticoids
10/22/2009US20090264392 Treating eosinophilic esophagitis
10/22/2009US20090264391 Fluocinolone Implants to Protect Against Undesirable Bone and Cartilage Destruction
10/22/2009US20090264390 Topical Personal Care Compositions And Methods of Use
10/22/2009US20090264389 Method of preparing dry powder inhalation compositions
10/22/2009US20090264388 Compounds and Methods of Treating Disorders Associated With Activation of Metachromatic Cells
10/22/2009US20090264387 Estra-1,3,5(10)-triene derivatives for contraception
10/22/2009US20090264386 Mesalamine suppository
10/22/2009US20090264385 Stabilized compositions containing alkaline labile drugs
10/22/2009US20090264384 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
10/22/2009US20090264383 Inhibitor of Adenylyl Cyclase for Treating a Disorder of the Circadian Rhythm
10/22/2009US20090264382 Methods for Treating Hematopoietic Neoplasms
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264380 6,11-bridged biaryl macrolides
10/22/2009US20090264379 Stable aqueous solution of a polyene fungicide
10/22/2009US20090264378 Avermectin compounds and treatment of dermatological disorders in humans therewith
10/22/2009US20090264377 Anti-neoplastic compositions comprising extracts of black cohosh
10/22/2009US20090264376 Hoodia plant extract with improved flavor
10/22/2009US20090264375 Intraocular irrigating solutions and methods for treating corneal edema
10/22/2009US20090264374 Utilization of anti-neuropathic pain effect of d-allose and d-psicose
10/22/2009US20090264368 Compositions for delivering parathyroid hormone and calcitonin
10/22/2009US20090264367 5-cnac as oral delivery agent for parathyroid hormone fragments
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264356 Adenovirus 36 E4 orf 1 Gene and Protein and Their Uses
10/22/2009US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
10/22/2009US20090264342 Compositions and methods for antibiotic potentiation and drug discovery
10/22/2009US20090264340 Compositions and methods for increasing the oral absorption of antimicrobials
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090264337 Cellular GPRS-communication linked glucometer - pedometer
10/22/2009US20090264336 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt ; deprotecting silanol group with an acid; type 2 diabetes
10/22/2009US20090263916 Antagonists of HMG1 for treating inflammatory conditions
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263783 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
10/22/2009US20090263522 Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
10/22/2009US20090263521 Composition for the treatment of cancers and inhibition of metastasis containing extracts or fractions of the magnolia obovata
10/22/2009US20090263513 Cosmetic skin lightening formulation
10/22/2009US20090263512 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
10/22/2009US20090263508 micronutrient supplement with calcium, vitamin d or calcium & vitamin d combination for premenstrual syndrome, postpartum depression, depression and panic attacks
10/22/2009US20090263504 Methods and compositions for promoting activity of anti-cancer therapies
10/22/2009US20090263495 Bacteriostatic or bacteriocidal compositions and methods
10/22/2009US20090263492 Diagnostic Methods and Genetic Markers for Alzheimer Disease
10/22/2009US20090263491 Polylactide Nanoparticles
10/22/2009US20090263489 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
10/22/2009US20090263488 Pressurised metered dose inhalers containing solutions of beta-2 agonists
10/22/2009US20090263486 Nanoparticle-stabilized capsule formulation for treatment of inflammation
10/22/2009US20090263484 Tissue Engineering Devices and Methods for Luminal Organs
10/22/2009US20090263483 Nanoparticle formulations and uses thereof
10/22/2009US20090263482 Treatment of inflammatory bowel disease with 6-mercaptopurine
10/22/2009US20090263481 Levetiracetam formulations
10/22/2009US20090263478 Carvedilol forms, compositions, and methods of preparation thereof
10/22/2009US20090263477 Salts of fenofibric acid and pharmaceutical formulations thereof
10/22/2009US20090263476 Composition of Rapid Disintegrating Direct Compression Buccal Tablet
10/22/2009US20090263475 Dexlansoprazole compositions
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263472 Endothelin receptor antagonist derivatives
10/22/2009US20090263471 Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation Thereof
10/22/2009US20090263469 Biguanide-containing liposomes
10/22/2009US20090263467 Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments
10/22/2009US20090263459 Methods and compositions for treating intervertebral disc herniations
10/22/2009US20090263453 Methods and Compositions for Treating Pain Comprising a Statin
10/22/2009US20090263452 Drug-eluting intravascular prostheses and methods of use
10/22/2009US20090263451 Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
10/22/2009US20090263450 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009US20090263449 Delivery of nucleic acid complexes from materials including negatively charged groups
10/22/2009US20090263444 Fluocinolone Formulations in a Biodegradable Polymer Carrier
10/22/2009US20090263443 Methods for treating post-operative effects such as spasticity and shivering with clondine
10/22/2009US20090263441 Drug depots having diffreent release profiles for reducing, preventing or treating pain and inflammation
10/22/2009US20090263438 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
10/22/2009US20090263436 Material primarily for medical, long-term in vivo use, and method for the production thereof
10/22/2009US20090263432 Stable combinations of amlodipine besylate and benazepril hydrochloride
10/22/2009US20090263413 Immunostimulatory oligonucleotides and use thereof in pharmaceuticals
10/22/2009US20090263408 Formulation and presentation of medicaments
10/22/2009US20090263407 Cationic Lipids and Uses Thereof
10/22/2009US20090263406 JY-1 Regulation Of Granulosa Cell Function And Early Embryonic Development In Cattle
10/22/2009US20090263405 CpG OLIGONUCLEOTIDE PRODRUGS, COMPOSITIONS THEREOF AND ASSOCIATED THERAPEUTIC METHODS
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263402 Growth Differentiation Factor-11
10/22/2009US20090263399 Method for establishing the sensitivity of tumours to capecitabin and test kit
10/22/2009US20090263398 Pharmaceutical combinations
10/22/2009US20090263397 Combination anti-cancer therapy
10/22/2009US20090263396 Inhibitors of t-darpp for use in combination anti-cancer therapies
1 ... 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 ... 7860